← 產業報告目錄

Defibrillator Market by Product (Implantable Cardioverter Defibrillator, External Defibrillator (Automated Defibrillator, Wearable Defibrillator, Manual Defibrillator)), End User (Hospitals & Clinics, Cardiac Centers, Homecare) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-08-13頁數 296報告編號 MD3124

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global defibrillator market is expected to reach USD 16.44 billion by 2030 from USD 11.99 billion in 2025, at a CAGR of 6.5% during the forecast period. The growth in the defibrillator market is driven by the increasing proportion of the population with cardiovascular diseases, technological advancements in defibrillators, and rising initiatives by public and private organizations to provide free training and programs, as well as enhance the implementation of public access defibrillators (PADs). However, issues related to implantable and automated external defibrillators and frequent product recalls have impeded market growth. The implantable cardioverter defibrillators segment accounted for the largest share of the global market in 2024. Based on product, the defibrillator market is broadly segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. ICDs are further divided into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators, whereas external defibrillators are divided into manual AEDs, automated AEDs, and wearable defibrillators. The ICDs segment accounted for the largest global defibrillator market share in 2024. Technological advancements in implantable defibrillators, rising awareness among cardiologists about the benefits pertaining to subcutaneous ICDs, and the launch of technologically advanced ICDs. The adult segment dominated the defibrillator market based on the patient type in 2024. The defibrillator market is segmented into adult and pediatric patients based on patient type. The adult patients segment dominated the global defibrillator market in 2024. The increasing incidence of cardiovascular disease in the adult population, rapid growth in the geriatric population, which is highly susceptible to sudden cardiac arrest, and the increasing number of implantations of ICDs in adult patients are likely to fuel the growth of the segment. North America is expected to account for the highest market share in the defibrillator market during the forecast period. Based on the region, the global defibrillator market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to witness a high market share during the forecast period. This can be attributed to factors such as the rising adoption of advanced defibrillators, increasing efforts by governments to provide the necessary care to cardiac arrest patients, the strong foothold of market players, favorable reimbursement programs, and an increase in the incidence of coronary artery diseases. Breakdown of supply-side primary interviews by company type, designation, and region: • By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%) • By Designation: C Level (35%), Director Level (25%), and Others (40%) • By Region: North America (40%), Asia Pacific (25%), Europe (20%), Latin America (10%), and Middle East & Africa (5%) Prominent companies include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Nihon Kohden Corporation (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea). Research Coverage This research report categorizes the defibrillator market by Product {Implantable cardioverter defibrillators [Transvenous implantable cardioverter defibrillators (Biventricular ICDS/cardiac resynchronization therapy defibrillators, dual-chamber ICDS, and single-chamber ICDS)], Subcutaneous implantable cardioverter defibrillators) External defibrillators [Manual External defibrillators, Automated external defibrillators (semi-automated external defibrillators, fully automated external defibrillators)], Wearable cardioverter defibrillators}, Patient type (Adult, Pediatric), End Users (Hospitals & Clinics, Cardiac centers, Prehospital settings, Public access markets, Home care settings, and Other end users), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the defibrillators market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies. Reasons to Buy the Report The report will help established firms, new entrants, and smaller firms gauge the pulse of the market, which in turn would help them gain a more significant share of the market. Firms purchasing the report could use one or any combination of the strategies mentioned below to strengthen their position in the market. This report provides insights into the following pointers: • Analysis of key drivers (rising prevalence of cardiovascular disease, increase in geriatric patient population, a strong focus of government to boost the installation of public access defibrillators, rising defibrillators training & programs, and expanding healthcare infrastructure), restraints (frequent product recalls, issues related to implantable and automated external defibrillators), opportunities (emerging countries, ongoing developments in ICDs/CRT-Ds, mergers and acquisitions among market players), and challenges (frequent product recalls and lack of awareness about the cardiac arrest in emerging countries) influencing the growth of the defibrillators market • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the defibrillator market • Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the defibrillator market • Market Development: Comprehensive information on lucrative emerging regions • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the defibrillator market • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
目錄 Table of Contents
1 INTRODUCTION 27 1.1 STUDY OBJECTIVES 27 1.2 MARKET DEFINITION 27 1.3 STUDY SCOPE 28 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 28 1.3.2 INCLUSIONS AND EXCLUSIONS 29 1.3.3 YEARS CONSIDERED 30 1.4 CURRENCY CONSIDERED 30 1.5 STAKEHOLDERS 31 1.6 SUMMARY OF CHANGES 31 2 RESEARCH METHODOLOGY 33 2.1 RESEARCH DATA 33 2.1.1 SECONDARY DATA 34 2.1.2 PRIMARY RESEARCH 35 2.1.2.1 Key data from primary sources 35 2.1.2.2 Key industry insights 36 2.2 MARKET SIZE ESTIMATION METHODOLOGY 37 2.2.1 PRODUCT-BASED MARKET ESTIMATION 39 2.2.2 END-USER-BASED MARKET ESTIMATION 39 2.2.3 PRIMARY RESEARCH VALIDATION 40 2.2.4 TOP-DOWN APPROACH 41 2.2.5 GROWTH RATE PROJECTIONS 41 2.3 DATA TRIANGULATION 42 2.4 RESEARCH ASSUMPTIONS 44 2.5 RESEARCH LIMITATIONS 44 2.6 RISK ANALYSIS 45 3 EXECUTIVE SUMMARY 46 4 PREMIUM INSIGHTS 52 4.1 DEFIBRILLATOR MARKET OVERVIEW 52 4.2 ASIA PACIFIC DEFIBRILLATOR MARKET, BY COUNTRY AND END USER 53 4.3 GEOGRAPHIC SNAPSHOT OF DEFIBRILLATOR MARKET 54   5 MARKET OVERVIEW 55 5.1 INTRODUCTION 55 5.2 MARKET DYNAMICS 55 5.2.1 DRIVERS 56 5.2.1.1 Growing prevalence of cardiovascular diseases 56 5.2.1.2 Increasing focus on public-access defibrillators 56 5.2.1.3 Training and awareness programs on defibrillators 57 5.2.2 RESTRAINTS 58 5.2.2.1 Frequent product recalls 58 5.2.3 OPPORTUNITIES 59 5.2.3.1 Untapped growth potential in emerging markets 59 5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds 59 5.2.4 CHALLENGES 60 5.2.4.1 Inadequate awareness of sudden cardiac arrest and limited access to healthcare 60 5.2.4.2 Challenges associated with pricing pressure 60 5.3 INDUSTRY TRENDS 61 5.3.1 NEXT GEN AI-ENABLED PATCH WEARABLE CARDIOVERTER DEFIBRILLATORS 61 5.3.2 CONNECTED AED ECOSYSTEM 61 5.3.3 EXPANSION IN EMERGING MARKETS AND PUBLIC ACCESS 61 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 62 5.5 PRICING ANALYSIS 62 5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 63 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 64 5.6 VALUE CHAIN ANALYSIS 65 5.7 SUPPLY CHAIN ANALYSIS 66 5.8 ECOSYSTEM ANALYSIS 67 5.9 INVESTMENT AND FUNDING SCENARIO 68 5.10 TECHNOLOGY ANALYSIS 68 5.10.1 KEY TECHNOLOGIES 68 5.10.1.1 Electrodes and gel pad technology 68 5.10.1.2 Handheld portable defibrillator 69 5.10.2 COMPLEMENTARY TECHNOLOGIES 69 5.10.2.1 Cardiopulmonary Resuscitation (CPR) feedback technology 69 5.10.2.2 Automated self-testing and device readiness monitoring 69 5.10.3 ADJACENT TECHNOLOGIES 70 5.10.3.1 Electronic Health Record (EHR) integration 70 5.11 PATENT ANALYSIS 70 5.11.1 JURISDICTION AND TOP APPLICANT ANALYSIS 70 5.12 TRADE ANALYSIS 74 5.12.1 IMPORT DATA FOR HS CODE 901890 74 5.12.2 EXPORT DATA FOR HS CODE 901890 74 5.13 KEY CONFERENCES AND EVENTS, 2025–2026 75 5.14 REGULATORY LANDSCAPE 76 5.14.1 REGULATORY FRAMEWORK 76 5.14.1.1 North America 76 5.14.1.1.1 US 76 5.14.1.1.2 Canada 76 5.14.1.2 Europe 76 5.14.1.3 Asia Pacific 76 5.14.1.4 Latin America 77 5.14.1.5 Middle East & Africa 77 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 5.15 PORTER’S FIVE FORCES ANALYSIS 81 5.15.1 BARGAINING POWER OF SUPPLIERS 82 5.15.2 BARGAINING POWER OF BUYERS 82 5.15.3 THREAT OF NEW ENTRANTS 83 5.15.4 THREAT OF SUBSTITUTES 83 5.15.5 INTENSITY OF COMPETITIVE RIVALRY 83 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 84 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 84 5.16.2 BUYING CRITERIA 85 5.17 REIMBURSEMENT SCENARIO 86 5.18 UNMET NEEDS/END-USER EXPECTATIONS 87 5.19 IMPACT OF AI/GEN AI ON DEFIBRILLATOR MARKET 88 5.19.1 INTRODUCTION 88 5.19.2 MARKET POTENTIAL OF AI IN DEFIBRILLATORS 88 5.19.3 AI USE CASES 88 5.19.4 KEY COMPANIES IMPLEMENTING AI 89 5.20 IMPACT OF 2025 US TARIFF 90 5.20.1 INTRODUCTION 90 5.20.2 KEY TARIFF RATES 91 5.20.3 PRICE IMPACT ANALYSIS 91 5.20.4 IMPACT ON COUNTRY/REGION 92 5.20.5 IMPACT ON END-USE SEGMENTS 95 6 DEFIBRILLATOR MARKET, BY PRODUCT 96 6.1 INTRODUCTION 97 6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 97 6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 100 6.2.1.1 Biventricular ICDs/Cardiac resynchronization therapy defibrillators 102 6.2.1.1.1 Growing improvements in battery technology to boost market 102   6.2.1.2 Dual-chamber ICDs 103 6.2.1.2.1 Ability to reduce incidence of inappropriate shocks to drive market 103 6.2.1.3 Single-chamber ICDs 105 6.2.1.3.1 Utilization of single-chamber ICDs for atrial monitoring to support growth 105 6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 106 6.2.2.1 Increasing preference for less-invasive approach to augment growth 106 6.3 EXTERNAL DEFIBRILLATORS 108 6.3.1 MANUAL EXTERNAL DEFIBRILLATORS 109 6.3.1.1 High portability and compact design to foster growth 109 6.3.2 AUTOMATED EXTERNAL DEFIBRILLATORS 111 6.3.2.1 Semi-automated external defibrillators 113 6.3.2.1.1 Growing initiatives for emergency medical services to fuel market 113 6.3.2.2 Fully automated external defibrillators 114 6.3.2.2.1 Rising installation of defibrillators in public places to favor growth 114 6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS 116 6.3.3.1 Increasing launches of wearable defibrillators to facilitate growth 116 7 DEFIBRILLATOR MARKET, BY PATIENT TYPE 118 7.1 INTRODUCTION 119 7.2 ADULT PATIENTS 119 7.2.1 INCREASING GERIATRIC POPULATION AND RISING BURDEN OF CARDIOVASCULAR DISEASES TO DRIVE MARKET 119 7.3 PEDIATRIC PATIENTS 120 7.3.1 RISING INCIDENCE OF PEDIATRIC HEART AILMENTS TO SUPPORT GROWTH 120 8 DEFIBRILLATOR MARKET, BY END USER 122 8.1 INTRODUCTION 123 8.2 HOSPITALS & CLINICS 123 8.2.1 HIGH VOLUME OF CARDIAC PROCEDURES TO EXPEDITE GROWTH 123 8.3 CARDIAC CENTERS 125 8.3.1 INCREASING CARDIOVASCULAR CASELOAD AND NEED FOR SPECIALIZED CARE TO BOOST MARKET 125 8.4 PREHOSPITAL SETTINGS 126 8.4.1 RISING FUNDING FOR EMERGENCY AMBULANCE SERVICES TO PROMOTE GROWTH 126 8.5 PUBLIC-ACCESS MARKETS 128 8.5.1 GROWING INCIDENCE OF SUDDEN CARDIAC ARRESTS TO PROPEL MARKET 128 8.6 HOME CARE SETTINGS 129 8.6.1 RISING ADOPTION OF HOME-AUTOMATED EXTERNAL DEFIBRILLATORS TO FOSTER GROWTH 129 8.7 OTHER END USERS 131 9 DEFIBRILLATOR MARKET, BY REGION 132 9.1 INTRODUCTION 133 9.2 NORTH AMERICA 134 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 134 9.2.2 US 138 9.2.2.1 High implant rates to contribute to growth 138 9.2.3 CANADA 141 9.2.3.1 High burden of cardiovascular diseases to support growth 141 9.3 EUROPE 144 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 144 9.3.2 GERMANY 148 9.3.2.1 Established healthcare system to favor growth 148 9.3.3 UK 151 9.3.3.1 Rising support from government & private organizations for accessibility of defibrillators to drive market 151 9.3.4 FRANCE 154 9.3.4.1 Favorable government initiatives to bolster growth 154 9.3.5 ITALY 157 9.3.5.1 High prevalence of out-of-hospital cardiac arrests to promote growth 157 9.3.6 SPAIN 160 9.3.6.1 Rising aging population to stimulate growth 160 9.3.7 REST OF EUROPE 163 9.4 ASIA PACIFIC 166 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 166 9.4.2 JAPAN 170 9.4.2.1 Booming geriatric population to foster growth 170 9.4.3 CHINA 173 9.4.3.1 Rising incidence of strokes to expedite growth 173 9.4.4 INDIA 176 9.4.4.1 Growing prevalence of cardiovascular diseases and government initiatives to drive market 176 9.4.5 AUSTRALIA 179 9.4.5.1 Increasing community access to defibrillators through policy and targeted funding to fuel market 179 9.4.6 SOUTH KOREA 182 9.4.6.1 Robust digital ecosystem and government-led health programs to boost market 182 9.4.7 REST OF ASIA PACIFIC 185   9.5 LATIN AMERICA 188 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 188 9.5.2 BRAZIL 191 9.5.2.1 Rising obesity rates to accelerate growth 191 9.5.3 MEXICO 194 9.5.3.1 Increasing infrastructure development to facilitate growth 194 9.5.4 REST OF LATIN AMERICA 197 9.6 MIDDLE EAST & AFRICA 200 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 200 9.6.2 GCC COUNTRIES 203 9.6.2.1 Kingdom of Saudi Arabia (KSA) 206 9.6.2.1.1 Expanding digital healthcare infrastructure to boost market 206 9.6.2.2 United Arab Emirates (UAE) 209 9.6.2.2.1 Increasing government investments for healthcare infrastructure to aid growth 209 9.6.2.3 Rest of GCC Countries 212 9.6.3 REST OF MIDDLE EAST & AFRICA 215 10 COMPETITIVE LANDSCAPE 219 10.1 INTRODUCTION 219 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 219 10.2.1 STRATEGIES ADOPTED BY KEY PLAYERS 219 10.2.2 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DEFIBRILLATOR MARKET 220 10.3 REVENUE ANALYSIS, 2022–2024 221 10.4 MARKET SHARE ANALYSIS, 2024 222 10.5 COMPANY VALUATION AND FINANCIAL METRICS 225 10.6 BRAND/PRODUCT COMPARISON 226 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 226 10.7.1 STARS 226 10.7.2 EMERGING LEADERS 227 10.7.3 PERVASIVE PLAYERS 227 10.7.4 PARTICIPANTS 227 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 228 10.7.5.1 Company footprint 228 10.7.5.2 Region footprint 228 10.7.5.3 Product footprint 229 10.7.5.4 Patient type footprint 230 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 231 10.8.1 PROGRESSIVE COMPANIES 231 10.8.2 RESPONSIVE COMPANIES 231 10.8.3 DYNAMIC COMPANIES 231 10.8.4 STARTING BLOCKS 231 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 233 10.8.5.1 Detailed list of key startups/SMEs 233 10.8.5.2 Competitive benchmarking of key startups/SMEs 233 10.9 COMPETITIVE SCENARIO 234 10.9.1 PRODUCT LAUNCHES AND APPROVALS 234 10.9.2 EXPANSIONS 235 10.9.3 DEALS 236 10.9.4 OTHER DEVELOPMENTS 237 11 COMPANY PROFILES 238 11.1 KEY PLAYERS 238 11.1.1 MEDTRONIC 238 11.1.1.1 Business overview 238 11.1.1.2 Products offered 239 11.1.1.3 Recent developments 242 11.1.1.3.1 Product launches and approvals 242 11.1.1.4 MnM view 243 11.1.1.4.1 Key strengths 243 11.1.1.4.2 Strategic choices 243 11.1.1.4.3 Weaknesses and competitive threats 243 11.1.2 BOSTON SCIENTIFIC CORPORATION 244 11.1.2.1 Business overview 244 11.1.2.2 Products offered 245 11.1.2.3 Recent developments 247 11.1.2.3.1 Deals 247 11.1.2.4 MnM view 247 11.1.2.4.1 Key strengths 247 11.1.2.4.2 Strategic choices 247 11.1.2.4.3 Weaknesses and competitive threats 247 11.1.3 ABBOTT 248 11.1.3.1 Business overview 248 11.1.3.2 Products offered 249 11.1.3.3 MnM view 250 11.1.3.3.1 Key strengths 250 11.1.3.3.2 Strategic choices 250 11.1.3.3.3 Weaknesses and competitive threats 250 11.1.4 ASAHI KASEI CORPORATION 251 11.1.4.1 Business overview 251 11.1.4.2 Products offered 252 11.1.4.3 MnM view 253 11.1.4.3.1 Key strengths 253 11.1.4.3.2 Strategic choices 253 11.1.4.3.3 Weaknesses and competitive threats 253 11.1.5 STRYKER 254 11.1.5.1 Business overview 254 11.1.5.2 Products offered 255 11.1.5.3 Recent developments 256 11.1.5.3.1 Product launches and approvals 256 11.1.5.3.2 Other developments 256 11.1.5.4 MnM view 256 11.1.5.4.1 Key strengths 256 11.1.5.4.2 Strategic choices 256 11.1.5.4.3 Weaknesses and competitive threats 256 11.1.6 KONINKLIJKE PHILIPS N.V. 257 11.1.6.1 Business overview 257 11.1.6.2 Products offered 258 11.1.6.3 Recent developments 259 11.1.6.3.1 Expansions 259 11.1.7 MICROPORT SCIENTIFIC CORPORATION 260 11.1.7.1 Business overview 260 11.1.7.2 Products offered 261 11.1.7.3 Recent developments 262 11.1.7.3.1 Product launches and approvals 262 11.1.8 NIHON KOHDEN CORPORATION 264 11.1.8.1 Business overview 264 11.1.8.2 Products offered 265 11.1.8.3 Recent developments 266 11.1.8.3.1 Expansions 266 11.1.9 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 267 11.1.9.1 Business overview 267 11.1.9.2 Products offered 268 11.1.9.3 Recent developments 269 11.1.9.3.1 Product launches and approvals 269 11.1.9.3.2 Other developments 269 11.1.10 BIOTRONIK 270 11.1.10.1 Business overview 270 11.1.10.2 Products offered 270 11.1.10.3 Recent developments 271 11.1.10.3.1 Expansions 271 11.1.11 CU MEDICAL SYSTEMS CO., LTD. 272 11.1.11.1 Business overview 272 11.1.11.2 Products offered 272   11.1.12 METSIS MEDIKAL 273 11.1.12.1 Business overview 273 11.1.12.2 Products offered 273 11.1.13 MEDIANA CO, LTD. 274 11.1.13.1 Business overview 274 11.1.13.2 Products offered 274 11.1.13.3 Recent developments 275 11.1.13.3.1 Other developments 275 11.1.14 PROGETTI SRL 276 11.1.14.1 Business overview 276 11.1.14.2 Products offered 276 11.1.14.3 Recent developments 277 11.1.14.3.1 Other developments 277 11.1.15 SCHILLER AG 278 11.1.15.1 Business overview 278 11.1.15.2 Products offered 278 11.1.15.3 Recent developments 279 11.1.15.3.1 Deals 279 11.1.15.3.2 Other developments 279 11.2 OTHER PLAYERS 280 11.2.1 BPL MEDICAL TECHNOLOGIES 280 11.2.2 METRAX GMBH 281 11.2.3 MS WESTFALIA GMBH 282 11.2.4 BEXEN CARDIO 283 11.2.5 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD. 284 11.2.6 AVIVE SOLUTIONS 284 11.2.7 AMI ITALIA 285 11.2.8 CORPULS 286 11.2.9 ALLIED MEDICAL LTD. 286 11.2.10 AXION CONCERN LLC 287 12 APPENDIX 288 12.1 DISCUSSION GUIDE 288 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 292 12.3 CUSTOMIZATION OPTIONS 294 12.4 RELATED REPORTS 294 12.5 AUTHOR DETAILS 295
圖表清單 List of Tables & Figures
TABLE 1 DEFIBRILLATOR MARKET: INCLUSIONS AND EXCLUSIONS 29 TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 30 TABLE 3 DEFIBRILLATOR MARKET: RISK ANALYSIS 45 TABLE 4 PERCENTAGE OF GLOBAL POPULATION AGED 65 YEARS, BY REGION, 2022 VS. 2030 VS. 2050 56 TABLE 5 PRODUCT RECALLS BY US FDA, 2021–2024 58 TABLE 6 AVERAGE SELLING PRICE TREND OF DEFIBRILLATORS, BY KEY PLAYER, 2022–2024 (USD) 63 TABLE 7 AVERAGE SELLING PRICE TREND OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS), BY REGION, 2022–2024 (USD) 64 TABLE 8 AVERAGE SELLING PRICE TREND OF EXTERNAL DEFIBRILLATORS, BY REGION, 2022–2024 (USD) 64 TABLE 9 DEFIBRILLATOR MARKET: ROLE OF COMPANIES IN ECOSYSTEM 67 TABLE 10 DEFIBRILLATOR MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2025 72 TABLE 11 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND) 74 TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND) 74 TABLE 13 DEFIBRILLATOR MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 75 TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 19 DEFIBRILLATOR MARKET: PORTER’S FIVE FORCES ANALYSIS 81 TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DEFIBRILLATOR 85 TABLE 21 KEY BUYING CRITERIA FOR DEFIBRILLATOR, BY PRODUCT 86 TABLE 22 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN US 86 TABLE 23 DEFIBRILLATOR MARKET: UNMET NEEDS/END-USER EXPECTATIONS 87 TABLE 24 US ADJUSTED RECIPROCAL TARIFF RATES, 2024 91 TABLE 25 KEY PRODUCT-RELATED TARIFF EFFECTIVE DEFIBRILLATOR 91 TABLE 26 NORTH AMERICA: IMPACT OF US TARIFF ON CANADA 92 TABLE 27 ASIA PACIFIC: IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA 93 TABLE 28 EUROPE: IMPACT OF US TARIFF ON GERMANY AND UK 94 TABLE 29 LATIN AMERICA: IMPACT OF US TARIFF ON MEXICO 94 TABLE 30 DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 97 TABLE 31 COMMERCIAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AVAILABLE IN MARKET 98 TABLE 32 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 98 TABLE 33 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 34 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 100 TABLE 35 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 36 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 37 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 38 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 39 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 40 COMMERCIAL EXTERNAL DEFIBRILLATORS AVAILABLE IN MARKET 108 TABLE 41 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 108 TABLE 42 EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 43 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 44 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 111 TABLE 45 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 46 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 47 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 48 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 49 DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 119 TABLE 50 DEFIBRILLATOR MARKET FOR ADULT PATIENTS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 51 DEFIBRILLATOR MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 52 DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 123 TABLE 53 DEFIBRILLATOR MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 54 DEFIBRILLATOR MARKET FOR CARDIAC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 55 DEFIBRILLATOR MARKET FOR PREHOSPITAL SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 56 DEFIBRILLATOR MARKET FOR PUBLIC-ACCESS MARKETS, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 57 DEFIBRILLATOR MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 58 DEFIBRILLATOR MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 59 DEFIBRILLATOR MARKET, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 60 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2023–2030 (THOUSAND) 133 TABLE 61 NORTH AMERICA: DEFIBRILLATOR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 62 NORTH AMERICA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 136 TABLE 63 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 136 TABLE 64 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 136 TABLE 65 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 137 TABLE 66 NORTH AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 137 TABLE 67 NORTH AMERICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 137 TABLE 68 NORTH AMERICA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 138 TABLE 69 US: KEY MACROECONOMIC INDICATORS 139 TABLE 70 US: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 139 TABLE 71 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 139 TABLE 72 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 140 TABLE 73 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 140 TABLE 74 US: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 140 TABLE 75 US: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 141 TABLE 76 US: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 141 TABLE 77 CANADA: KEY MACROECONOMIC INDICATORS 142 TABLE 78 CANADA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 142 TABLE 79 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 142 TABLE 80 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 143 TABLE 81 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 143 TABLE 82 CANADA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 143 TABLE 83 CANADA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 144 TABLE 84 CANADA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 144 TABLE 85 EUROPE: DEFIBRILLATOR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 86 EUROPE: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 145 TABLE 87 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 88 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 89 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 90 EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 147 TABLE 91 EUROPE: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 147 TABLE 92 EUROPE: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 93 GERMANY: KEY MACROECONOMIC INDICATORS 148 TABLE 94 GERMANY: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 148 TABLE 95 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 96 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 97 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 98 GERMANY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 99 GERMANY: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 150 TABLE 100 GERMANY: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 150 TABLE 101 UK: KEY MACROECONOMIC INDICATORS 151 TABLE 102 UK: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 152 TABLE 103 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET, BY TYPE, 2023–2030 (USD MILLION) 152 TABLE 104 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 USD MILLION) 152 TABLE 105 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 106 UK: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 107 UK: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 153 TABLE 108 UK: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 109 FRANCE: KEY MACROECONOMIC INDICATORS 154 TABLE 110 FRANCE: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 155 TABLE 111 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 155 TABLE 112 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 155 TABLE 113 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 114 FRANCE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 115 FRANCE: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 156 TABLE 116 FRANCE: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 157 TABLE 117 ITALY: KEY MACROECONOMIC INDICATORS 158 TABLE 118 ITALY: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 158 TABLE 119 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 120 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 121 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 122 ITALY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 123 ITALY: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 160 TABLE 124 ITALY: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 125 SPAIN: KEY MACROECONOMIC INDICATORS 161 TABLE 126 SPAIN: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 161 TABLE 127 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 128 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 129 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 130 SPAIN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 131 SPAIN: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 163 TABLE 132 SPAIN: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 133 REST OF EUROPE: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 164 TABLE 134 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 135 REST OF EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 136 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 137 REST OF EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 138 REST OF EUROPE: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 165 TABLE 139 REST OF EUROPE: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 166 TABLE 140 ASIA PACIFIC: DEFIBRILLATOR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 141 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 168 TABLE 142 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 143 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 144 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 145 ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 146 ASIA PACIFIC: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 170 TABLE 147 ASIA PACIFIC: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 148 JAPAN: KEY MACROECONOMIC INDICATORS 171 TABLE 149 JAPAN: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 171 TABLE 150 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 151 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 152 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 153 JAPAN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 154 JAPAN: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 173 TABLE 155 JAPAN: DEFIBRILLATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 156 CHINA: KEY MACROECONOMIC INDICATORS 174 TABLE 157 CHINA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 174 TABLE 158 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 159 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 160 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 161 CHINA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 162 CHINA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 176 TABLE 163 CHINA: EXTERNAL DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 176 TABLE 164 INDIA: KEY MACROECONOMIC INDICATORS 177 TABLE 165 INDIA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 177 TABLE 166 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 167 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 168 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 169 INDIA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 170 INDIA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 179 TABLE 171 INDIA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 172 AUSTRALIA: KEY MACROECONOMIC INDICATORS 180 TABLE 173 AUSTRALIA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 180 TABLE 174 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 175 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 176 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 177 AUSTRALIA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 178 AUSTRALIA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 182 TABLE 179 AUSTRALIA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 182 TABLE 180 SOUTH KOREA: KEY MACROECONOMIC INDICATORS 183 TABLE 181 SOUTH KOREA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 183 TABLE 182 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 183 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 184 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 185 SOUTH KOREA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 186 SOUTH KOREA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 185 TABLE 187 SOUTH KOREA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 185 TABLE 188 REST OF ASIA PACIFIC: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 186 TABLE 189 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 190 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 191 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 192 REST OF ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 193 REST OF ASIA PACIFIC: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 187 TABLE 194 REST OF ASIA PACIFIC: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 188 TABLE 195 LATIN AMERICA: DEFIBRILLATOR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 196 LATIN AMERICA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 189 TABLE 197 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 198 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 199 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 200 LATIN AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 201 LATIN AMERICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 191 TABLE 202 LATIN AMERICA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 191 TABLE 203 BRAZIL: KEY MACROECONOMIC INDICATORS 192 TABLE 204 BRAZIL: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 192 TABLE 205 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 206 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 207 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 208 BRAZIL: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 209 BRAZIL: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 194 TABLE 210 BRAZIL: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 194 TABLE 211 MEXICO: KEY MACROECONOMIC INDICATORS 195 TABLE 212 MEXICO: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 195 TABLE 213 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 214 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 215 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 216 MEXICO: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 217 MEXICO: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 197 TABLE 218 MEXICO: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 197 TABLE 219 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 198 TABLE 220 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 221 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 222 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 223 REST OF LATIN AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 224 REST OF LATIN AMERICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 199 TABLE 225 REST OF LATIN AMERICA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 200 TABLE 226 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY REGION, 2023–2030 (USD MILLION) 201 TABLE 227 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 201 TABLE 228 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 229 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 230 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 231 MIDDLE EAST & AFRICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 232 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 203 TABLE 233 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 203 TABLE 234 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 235 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 204 TABLE 236 GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 237 GCC COUNTRIES: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 238 GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 239 GCC COUNTRIES: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 240 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 206 TABLE 241 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 206 TABLE 242 KINGDOM OF SAUDI ARABIA (KSA): KEY MACROECONOMIC INDICATORS 207 TABLE 243 KINGDOM OF SAUDI ARABIA (KSA): DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 207 TABLE 244 KINGDOM OF SAUDI ARABIA (KSA): IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 245 KINGDOM OF SAUDI ARABIA (KSA): TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 246 KINGDOM OF SAUDI ARABIA (KSA): EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 247 KINGDOM OF SAUDI ARABIA (KSA): AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 248 KINGDOM OF SAUDI ARABIA (KSA): DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 209 TABLE 249 KINGDOM OF SAUDI ARABIA (KSA): DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 209 TABLE 250 UAE: KEY MACROECONOMIC INDICATORS 210 TABLE 251 UAE: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 210 TABLE 252 UAE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 253 UAE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 254 UAE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 255 UAE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 256 UAE: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 212 TABLE 257 UAE: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 212 TABLE 258 REST OF GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 213 TABLE 259 REST OF GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 260 REST OF GCC COUNTRIES: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 261 REST OF GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 262 REST OF GCC COUNTRIES: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 263 REST OF GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 214 TABLE 264 REST OF GCC COUNTRIES: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 215 TABLE 265 REST OF MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 216 TABLE 266 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 267 REST OF MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 268 REST OF MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 269 REST OF MIDDLE EAST & AFRICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 270 REST OF MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 217 TABLE 271 REST OF MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 218 TABLE 272 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DEFIBRILLATOR MARKET 220 TABLE 273 IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICDS) MARKET: DEGREE OF COMPETITION 222 TABLE 274 EXTERNAL DEFIBRILLATOR MARKET: DEGREE OF COMPETITION 223 TABLE 275 DEFIBRILLATOR MARKET: REGION FOOTPRINT 228 TABLE 276 DEFIBRILLATOR MARKET: PRODUCT FOOTPRINT 229 TABLE 277 DEFIBRILLATOR MARKET: PATIENT TYPE FOOTPRINT 230 TABLE 278 DEFIBRILLATOR MARKET: DETAILED LIST OF KEY STARTUPS/SMES 233 TABLE 279 DEFIBRILLATOR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 233 TABLE 280 DEFIBRILLATOR MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MAY 2025 234 TABLE 281 DEFIBRILLATOR MARKET: EXPANSIONS, JANUARY 2022–MAY 2025 235 TABLE 282 DEFIBRILLATOR MARKET: DEALS, JANUARY 2022–MAY 2025 236 TABLE 283 DEFIBRILLATOR MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 237 TABLE 284 MEDTRONIC: COMPANY OVERVIEW 238 TABLE 285 MEDTRONIC: PRODUCTS OFFERED 239 TABLE 286 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022– MAY 2025 242 TABLE 287 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 244 TABLE 288 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 245 TABLE 289 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–MAY 2025 247 TABLE 290 ABBOTT: COMPANY OVERVIEW 248 TABLE 291 ABBOTT: PRODUCTS OFFERED 249 TABLE 292 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 251 TABLE 293 ASAHI KASEI CORPORATION: PRODUCTS OFFERED 252 TABLE 294 STRYKER: COMPANY OVERVIEW 254 TABLE 295 STRYKER: PRODUCTS OFFERED 255 TABLE 296 STRYKER: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MAY 2025 256 TABLE 297 STRYKER: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 256 TABLE 298 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 257 TABLE 299 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 258 TABLE 300 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022–MAY 2025 259 TABLE 301 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 260 TABLE 302 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 261 TABLE 303 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MAY 2025 262 TABLE 304 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 264 TABLE 305 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 265 TABLE 306 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2022–MARCH 2025 266 TABLE 307 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 267 TABLE 308 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 268 TABLE 309 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MAY 2025 269 TABLE 310 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 269 TABLE 311 BIOTRONIK: COMPANY OVERVIEW 270 TABLE 312 BIOTRONIK: PRODUCTS OFFERED 270 TABLE 313 BIOTRONIK: EXPANSIONS, JANUARY 2022–MAY 2025 271 TABLE 314 CU MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW 272 TABLE 315 CU MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED 272 TABLE 316 METSIS MEDIKAL: COMPANY OVERVIEW 273 TABLE 317 METSIS MEDIKAL: PRODUCTS OFFERED 273 TABLE 318 MEDIANA CO., LTD.: COMPANY OVERVIEW 274 TABLE 319 MEDIANA CO., LTD.: PRODUCTS OFFERED 274 TABLE 320 MEDIANA CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 275 TABLE 321 PROGETTI SRL: COMPANY OVERVIEW 276 TABLE 322 PROGETTI SRL: PRODUCTS OFFERED 276 TABLE 323 PROGETTI SRL: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 277 TABLE 324 SCHILLER AG: COMPANY OVERVIEW 278 TABLE 325 SCHILLER AG: PRODUCTS OFFERED 278 TABLE 326 SCHILLER AG.: DEALS, JANUARY 2022–MAY 2025 279 TABLE 327 SCHILLER AG.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 279 TABLE 328 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW 280 TABLE 329 METRAX GMBH: COMPANY OVERVIEW 281 TABLE 330 MS WESTFALIA GMBH: COMPANY OVERVIEW 282 TABLE 331 BEXEN CARDIO: COMPANY OVERVIEW 283 TABLE 332 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: COMPANY OVERVIEW 284 TABLE 333 AVIVE SOLUTIONS: COMPANY OVERVIEW 284 TABLE 334 AMI ITALIA: COMPANY OVERVIEW 285 TABLE 335 CORPLUS: COMPANY OVERVIEW 286 TABLE 336 ALLIED MEDICAL LTD.: COMPANY OVERVIEW 286 TABLE 337 AXION CONCERN LLC: COMPANY OVERVIEW 287 FIGURE 1 DEFIBRILLATOR MARKET SEGMENTATION AND REGIONAL SCOPE 28 FIGURE 2 DEFIBRILLATOR MARKET: YEARS CONSIDERED 30 FIGURE 3 DEFIBRILLATOR MARKET: RESEARCH DESIGN 33 FIGURE 4 DEFIBRILLATOR MARKET: KEY DATA FROM PRIMARY SOURCES 35 FIGURE 5 DEFIBRILLATOR MARKET: INSIGHTS FROM PRIMARIES 36 FIGURE 6 DEFIBRILLATOR MARKET: BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS) 37 FIGURE 7 DEFIBRILLATOR MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 37 FIGURE 8 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 38 FIGURE 9 DEFIBRILLATOR MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2024 39 FIGURE 10 DEFIBRILLATOR MARKET: MARKET SIZE ESTIMATION 40 FIGURE 11 DEFIBRILLATOR MARKET: TOP-DOWN APPROACH 41 FIGURE 12 DEFIBRILLATOR MARKET: CAGR PROJECTIONS (SUPPLY SIDE) 42 FIGURE 13 DATA TRIANGULATION METHODOLOGY 42 FIGURE 14 DEFIBRILLATOR MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 46 FIGURE 15 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS) MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 47 FIGURE 16 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 47 FIGURE 17 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 48 FIGURE 18 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 49 FIGURE 19 DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023 VS. 2030 49 FIGURE 20 DEFIBRILLATOR MARKET, BY END USER, 2025 VS. 2030 50 FIGURE 21 GEOGRAPHICAL SNAPSHOT OF DEFIBRILLATOR MARKET 51 FIGURE 22 RISING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET 52 FIGURE 23 HOSPITALS & CLINICS SEGMENT AND CHINA LED DEFIBRILLATOR MARKET IN 2024 53 FIGURE 24 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 54 FIGURE 25 DEFIBRILLATOR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55 FIGURE 26 REVENUE SHIFT AND NEW REVENUE POCKETS FOR DEFIBRILLATOR MARKET 62 FIGURE 27 AVERAGE SELLING PRICE OF EXTERNAL DEFIBRILLATORS, BY KEY PLAYER, 2024 (USD) 63 FIGURE 28 DEFIBRILLATOR MARKET: VALUE CHAIN ANALYSIS 65 FIGURE 29 DEFIBRILLATOR MARKET: SUPPLY CHAIN ANALYSIS 66 FIGURE 30 DEFIBRILLATOR MARKET: ECOSYSTEM ANALYSIS 67 FIGURE 31 DEFIBRILLATOR MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2023 68 FIGURE 32 DEFIBRILLATOR MARKET: PATENT ANALYSIS, JANUARY 2014–JUNE 2025 71 FIGURE 33 DEFIBRILLATOR MARKET: PORTER'S FIVE FORCES ANALYSIS 82 FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DEFIBRILLATOR 84 FIGURE 35 KEY BUYING CRITERIA FOR DEFIBRILLATOR, BY PRODUCT 85 FIGURE 36 DEFIBRILLATOR MARKET: AI USE CASES 89 FIGURE 37 NORTH AMERICA: DEFIBRILLATOR MARKET SNAPSHOT 135 FIGURE 38 ASIA PACIFIC: DEFIBRILLATOR MARKET SNAPSHOT 167 FIGURE 39 DEFIBRILLATOR MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS, 2022–2024 221 FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICDS) MARKET, 2024 222 FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN EXTERNAL DEFIBRILLATOR MARKET, 2024 223 FIGURE 42 RANKING OF KEY PLAYERS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, 2024 224 FIGURE 43 EV/EBITDA OF KEY VENDORS 225 FIGURE 44 YEAR-TO-DATE PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 225 FIGURE 45 DEFIBRILLATOR MARKET: BRAND/PRODUCT COMPARISON 226 FIGURE 46 DEFIBRILLATOR MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 227 FIGURE 47 DEFIBRILLATOR MARKET: COMPANY FOOTPRINT 228 FIGURE 48 DEFIBRILLATOR MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 232 FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT (2024) 239 FIGURE 50 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 245 FIGURE 51 ABBOTT: COMPANY SNAPSHOT (2024) 249 FIGURE 52 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2024) 252 FIGURE 53 STRYKER: COMPANY SNAPSHOT (2024) 255 FIGURE 54 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 258 FIGURE 55 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 261 FIGURE 56 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2024) 265 FIGURE 57 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2024) 268

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們